Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis

Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis

Background Non-alcoholic fatty liver disease is a prohaemostatic state with abnormal primary, secondary and tertiary haemostasis. Plasminogen activator inhibitor (PAI)-1 is the best-established marker for prohaemostasis in non-alcoholic fatty liver disease. While epidemiological studies demonstrate...

Full description

Saved in:
Bibliographic Details
Main Authors: Dmitri Bezinover, Gloriany Rivas, Breianna Hummer-Bair, Zakiyah Kadry, Jonathan Stine
Format: Article
Language:English
Published: BMJ Publishing Group 2021-10-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/8/1/e000683.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items